- Home
- PSHG vs INKT Comparison
PSHG vs INKT Comparison
Compare PSHG & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSHG
- INKT
- Stock Information
- Founded
- PSHG 2010
- INKT 2017
- Country
- PSHG Greece
- INKT United States
- Employees
- PSHG N/A
- INKT N/A
- Industry
- PSHG Marine Transportation
- INKT Medicinal Chemicals and Botanical Products
- Sector
- PSHG Consumer Discretionary
- INKT Health Care
- Exchange
- PSHG Nasdaq
- INKT Nasdaq
- Market Cap
- PSHG 24.2M
- INKT 28.5M
- IPO Year
- PSHG N/A
- INKT 2021
- Fundamental
- Price
- PSHG $1.94
- INKT $0.75
- Analyst Decision
- PSHG Strong Buy
- INKT Strong Buy
- Analyst Count
- PSHG 1
- INKT 2
- Target Price
- PSHG $6.50
- INKT $6.50
- AVG Volume (30 Days)
- PSHG 71.0K
- INKT 32.0K
- Earning Date
- PSHG 11-07-2024
- INKT 11-14-2024
- Dividend Yield
- PSHG N/A
- INKT N/A
- EPS Growth
- PSHG N/A
- INKT N/A
- EPS
- PSHG 1.51
- INKT N/A
- Revenue
- PSHG $89,608,000.00
- INKT N/A
- Revenue This Year
- PSHG N/A
- INKT N/A
- Revenue Next Year
- PSHG $2.66
- INKT N/A
- P/E Ratio
- PSHG $1.29
- INKT N/A
- Revenue Growth
- PSHG N/A
- INKT N/A
- 52 Week Low
- PSHG $1.70
- INKT $0.57
- 52 Week High
- PSHG $2.58
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- PSHG 45.55
- INKT 54.46
- Support Level
- PSHG $1.95
- INKT $0.74
- Resistance Level
- PSHG $2.04
- INKT $0.80
- Average True Range (ATR)
- PSHG 0.08
- INKT 0.05
- MACD
- PSHG -0.01
- INKT 0.01
- Stochastic Oscillator
- PSHG 33.87
- INKT 62.60
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.